news.google.com
Wall Street Journal
LONDON (Dow Jones)-- AstraZeneca PLC (AZN.LN) said Friday it will not appeal a ruling by a British regulatory panel that found the UK drug maker failed to ...
and more »
news.google.com
BusinessWeek
AstraZeneca Plc slid 1.5 percent after an experimental cancer treatment failed to match Roche Holding AG's Avastin in tests. The Stoxx Europe 600 Index ...
London: Petrofac Rises; Forth Ports Soars 123Jump.com
UK Stocks Advance; Petrofac, Standard Chartered Lead Gains BusinessWeek
all 24 news articles »
news.google.com
Philadelphia Inquirer
AP AstraZeneca PLC announced a supply partnership with India's Torrent Pharmaceuticals Ltd., its first such link with a maker of generic drugs as it seeks ...
and more »
news.google.com
Forbes
AP , 03.11.10, 05:52 am est london -- AstraZeneca PLC announced a supply partnership with India's Torrent Pharmaceuticals on Thursday, its first tie-up with ...
news.google.com
Reuters
The overall result could color perception of a pill awaiting a US approval decision that combines TriLipix with AstraZeneca's (AZN. ...
and more »
news.google.com
Leicester Mercury
Staff facing the axe from drugs giant AstraZeneca are planning to set up their own firms. Eight staff at the Loughborough research plant began a crash ...
news.google.com
BusinessWeek
Not only is he chief executive of AstraZeneca (AZN), one of the world's biggest pharmaceutical companies, but the group he leads, and the industry he is ...
Patent priorities key to pharma strategies, says CEO IP Review Online
all 2 news articles »
news.google.com
Proactive Investors UK
Pharmaceutical company AstraZeneca (LSE: AZN) announced a license and supply agreement with Torrent Pharmaceuticals Ltd. Torrent will supply to AstraZeneca ...
news.google.com
Comtex Smartrend
AstraZeneca (NYSE:AZN) upgraded to Neutral from Sell at Goldman. The stock closed yesterday at $43.14 on volume of ...
Goldman Sachs Upgrades AstraZeneca (AZN) and GlaxoSmithKline (GSK) to Neutral StreetInsider.com (subscription)
all 5 news articles »
news.google.com
Wall Street Journal
Though the latest quarter's results disappointed, the company has been on a roll, with a big deal in September to license two drugs to AstraZeneca PLC (AZN, ...
Nektar Therapeutics' President and CEO Howard W. Robin to Present at the 30th ... MarketWatch (press release)
Nektar shares rise as analysts looks to pipeline The Associated Press
Nektar Therapeutics Reports Year-End 2009 Financial Results PR Newswire (press release)
all 167 news articles »
news.google.com
The Guardian
AstraZeneca has raised its earnings forecasts for the year after paying 505m to settle a long running dispute with the UK tax authorities. ...
news.google.com
PR Newswire (press release)
In February 2010 Rigel announced the signing of a worldwide license agreement with AstraZeneca AB for certain of its oral Syk inhibitors, including the ...
Rigel narrows 4th-qtr loss as research costs fall BusinessWeek
Rigel Pharma Q4 Loss Narrows - Quick Facts RTT News
all 23 news articles »
news.google.com
Reuters
Other pharma companies also slipped, with AstraZeneca (AZN.L), Merck (MRCG.DE), Novartis (NOVN.VX), Novo Nordisk (NOVOb.CO), Roche Holding (ROG. ...
and more »
news.google.com
Worcester Telegram
AstraZeneca Plc, the UK's second-biggest drug maker, which has a facility in Westboro, sued India's Sun Pharmaceuticals Industries Ltd. to prevent it from ...
and more »
news.google.com
Reuters
L) AstraZeneca (AZN.L) and Pfizer (PFE.N), are faced with the loss of patent protection and cuts to government healthcare budgets, forcing radical cuts to ...
and more »
news.google.com
Lexology (registration)
The allegations in this case are similar to those arising in the European Commission's decision in the AstraZeneca case (currently on appeal). ...
news.google.com
Forbes
Device maker records earnings bump, AstraZeneca hikes forecast, and Gilead Sciences gets FDA OK on new drug. Medtronic posted a 19% increase in its fiscal ...
and more »
news.google.com
Benzinga
AstraZeneca decreased 1.78% to $44.65 in the pre-market session. The 52-week trading range for AZN is $29.96 - $50.70. AZN has surged over 48% in the last ...
Morning Stock Losers (AZN, HPQ, KFT, LXRX) Emailwire (press release) (blog)
all 3 news articles »
news.google.com
The News Journal
AstraZeneca Plc's promotion of the antipsychotic Seroquel, its second-best seller, to doctors may have breached the British pharmaceutical industry's code ...
Trial Spotlights Pentagon Use of Unapproved Antipsychotics for Post-Traumatic ... BNET
all 2 news articles »
news.google.com
Motley Fool
Bristol-Myers also has high hopes for its diabetes drug Onglyza, which it markets with AstraZeneca (NYSE: AZN). That one will be a hard sell given that it's ...
B-MS says five new drugs will soften the blow of Plavix loss Pharma Times
all 97 news articles »
From Google News Search: 'astrazeneca'
Sun Mar 14 12:28:01 2010 [ refresh local cache ]
[Hide]▼
images.scotsman.com
246px x 315px | 17.10kB
[source page]
Sat 16 Dec 2006 An AstraZeneca research facility is seen in Boston in an undated publicity photo Several major U S retailers have sued AstraZeneca Plc accusing the drugmaker of using illegal tactics to
pharmagossip.blogspot.com
insider
ue, 22 Sep 2009 21:58:01 GM
An . AstraZeneca. saleswoman told a U.S. doctor the antipsychotic Seroquel didn't cause diabetes almost four years after the company warned Japanese physicians about the drug's links to the disease, internal documents show. ...
What changes in regulatory affairs have been made at AstraZeneca? How do they develop a regulatory strategy?
Q. Any info would be greatly appreciated! I'm also curious about the structure of the dept...who reports to to who, how do they react to suprises, etc.?
Asked by thehairofelguapo - Tue Aug 22 17:30:49 2006 - - 2 Answers - 0 Comments
A. i have to be honest and show my ignorance in that i have no idea who/what AstraZeneca is... and it seems like no-one else does either...
Answered by charlie123 - Wed Aug 30 08:24:41 2006
Q. Any info would be greatly appreciated! I'm also curious about the structure of the dept...who reports to to who, how do they react to suprises, etc.?
Asked by thehairofelguapo - Tue Aug 22 17:30:49 2006 - - 2 Answers - 0 Comments
A. i have to be honest and show my ignorance in that i have no idea who/what AstraZeneca is... and it seems like no-one else does either...
Answered by charlie123 - Wed Aug 30 08:24:41 2006
[Hide]▲
